Novo Tellus, an investment firm specialising in long-term investments in the global supply chain, completed the investment in Amsino Medical Group, a global provider of medical consumable devices. Financial terms were not disclosed. "We're excited to renew a long-term partnership with Novo Tellus. Novo Tellus has proven itself as a growth partner for Amsino before, and shares our fundamental commitment to delivering dependable innovation and value to our customers around the world," Dr. Richard Y. Lee, Amsino Medical Group Chairman and CEO.